Arca biopharma announces 2021 financial results and provides corporate update

Topline data from phase 2b aspen-covid-19 clinical trial evaluating rnapc2 as a potential treatment for covid-19 anticipated in the last week of march 2022 topline data from phase 2b aspen-covid-19 clinical trial evaluating rnapc2 as a potential treatment for covid-19 anticipated in the last week of march 2022
ABIO Ratings Summary
ABIO Quant Ranking